Validation of a virus neutralization potency test in BHK-21 cells for rabies immunoglobulins in a two-center study

Journal of Virological Methods

Volumn 154, Issue 1-2, 2008, Pages 7-13

  de Moura, Wlamir Corrêa ^a   Gallina, Neuza Maria Frazatti ^b   Fuches, Regina Maria Mourão ^b   Romijn, Phyllis Catharina ^c   Leite, José Paulo Gagliardi ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

^c Secretaria Estadual de Saude   (Brazil)

Author keywords

Rabies; RFFIT; Validation; Virus neutralization test

Indexed keywords

RABIES IMMUNOGLOBULIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; INTERRATER RELIABILITY; INTRARATER RELIABILITY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RABIES VIRUS; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; BRAZIL; CELL LINE; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUTRALIZATION TESTS; RABIES; RABIES VIRUS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EQUIDAE; RABIES VIRUS;

EID: 56249088285     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.09.010     Document Type: Article

References (36)

1. Ark A., Kappelle I.S., Ólander R.M., Enssle K., Jadhav S., Donk H., and Hendriksen C.F.M. The Pertussis Serological Potency test collaborative study to evaluate replacement of the mouse protection test. Biologicals 28 (2000) 105-118
2. Atanasiu P. Quantitative assay and potency test of rabies serum and immunoglobulin. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva 314-318
3. Australian Government, March, 2006. Therapeutic Goods Administration, Finished Product (Medicine) Analytical Procedure Validation for Complementary Medicines, Available at: http://www.tga.gov.au/cm/finishval.pdf.
4. Balls M., Botham P., Cordier A., Fumero S., Kayser D., Koëter H., Koundakjian P., Lindquist N.G., Meyer O., Pioda L., Reinhardt C., Rozemond H., Smyrniotis T., Spielmann H., Van Looy H., van der Venne M.-T., and Walum E. Report and recommendations of an international workshop on promotion of the regulatory acceptance of validated non-animal toxicity test procedures. ATLA 18 (1990) 339-344
5. Bland, M.J., 2005. How should I calculate a within-subject coefficient of variation? Available at: http://www-users.york.ac.uk/∼mb55/meas/cv.htm.
6. Bland M.J., and Altman D.G. Statistics notes: measurement error proportional to the mean. BMJ 313 July (1996) 106
7. Bland M.J., and Kerry S.M. Statistics notes: weighted comparison of means. BMJ 316 (1998) 129
8. Cabasso V.J. Local wound treatment and passive immunization. In: Baer G.M. (Ed). The Natural History of Rabies. 2nd ed. (1991), CRC, Florida 551-570
9. Cliquet F., Aubert M., and Saugné L. Development of a fluorescent antibody virus neutralization test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods 212 (1998) 79-87
10. Council of Europe, 2005a. Assays depending upon quantal responses. (Chapter - General texts - 4). In: The European Pharmacopoeia, 5th ed. Strasbourg, France, pp. 484-486.
11. Council of Europe, 2005b. Human rabies immunoglobulin (Monograph No. 0723). In: The European Pharmacopoeia, 5th ed. Strasbourg, France, pp. 1750-1751.
12. Farmacopéia Brasileira, 2004. Fascículo 5-4a Ed. parte II. Soro Anti-rábico. monografia 109. Atheneu Ed. São Paulo, SP, Brasil.
13. Fitzgerald E.A., and Rastogi S.C. A collaborative study to establish an International Standard Rabies immunoglobulin of human origin. J. Biol. Stand. 13 (1985) 327-333
14. Fitzgerald E.A. Potency test for anti-rabies serum and immunoglobulin. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva 417-422
15. Frazier J.M., 1990. Scientific criteria for validation of in vitro toxicity tests. OECD Environment Monograph Number 36. Paris: Organization for Economic Co-operation and Development (OECD) 36, pp. 1-62.
16. Guillemin F., Tixier G., Soulebot J.P., and Chappuis G. Comparison de deux methods de titrage des anticorps antirabiques neutralizants. J. Biol. Stand. 9 (1981) 147-156
17. Guillemin F., Tixier G., Soulebot J.P., and Chappuis G. Rèsultats coparés des anticorps antirabiques per deux méthods utilisant ĺimmunofluorescence. J. Biol. Stand. 9 (1981) 157-160
18. Jacobson R.H. Validation of serological assay for diagnosis of infectious diseases. Rev. Sci. Tech. Off. Int. Epiz. 17 2 (1998) 469-486
19. Louie R.E., Dobkin M.B., Meyer P., Chin B., Roby R.E., Hammar A.H., and Cabasso V.J. Measurement of rabies antibody: comparison of the mouse neutralization test with the rapid fluorescent focus inhibition test. J. Biol. Stand. 3 (1975) 365-368
20. Metz B., Hendriksen C.F.M., Jiskoot W., and Kersten G.F.A. Reduction of animal use in human vaccine quality control: opportunities and problems. Vaccine 20 (2002) 2411-2430
21. NIEHS (National Institute of Environmental Health Sciences), 1997. Validation and regulatory acceptance of toxicological test methods: a report of the ad hoc Interagency Coordinating Committee on the validation of alternative methods, NIH Publication No. 97-3981, NIEHS, Research Triangle Park, North Carolina, U.S.A., Available at: http://iccvam.niehs.nih.gov/docs/about_docs/validate.pdf.
22. Plikaytis B.D., Goldblatt D., Frasch E., Blondeau C., Bybel M.J., Gienbink G.S., Jonsdottir I., Käyhty H., Konradsen H.B., Madore D.V., Nahm M.H., Schulman C.A., Holder P.F., Lezhava T., Elie C.M., and Carlone G.M. An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J. Clin. Microbiol. 38 6 (2000) 2043-2050
23. Robinson J. Bioassays-a continuously developing field. Drug Discov. Today 8 15 (2003) 676-678
24. Smith J.S., Yager P.A., and Baer G.M. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva 181-192
25. Smith J.S., Yager P.A., and Baer G.M. A rapid reproducible test for determining rabies neutralizing antibody. Bull. World Health Organ. 48 (1973) 535-541
26. Smith J.S. Rabies serology. In: Baer G.M. (Ed). The Natural History of Rabies. 2nd ed. (1991), CRC, Florida 235-252
27. Trimarchi C.V., Rudd R.D., and Safford Jr. M. An in vitro virus neutralization test for rabies antibody. In: Meslin F.X., Kaplan M.M., and Koprowski H. (Eds). Laboratory Techniques in Rabies (1996), WHO, Geneva 193-199
28. United States Pharmacopoeia-USP29, 2007, NF24. Monographs: Rabies Immune Globulin; p. 1887.
29. Webster L.T., and Dawson J.R. Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test. Proc. Soc. Exp. Biol. Med. 32 (1935) 570-573
30. World Health Organization, 1998. Expert Committee on Biological Standardization. 39th report. Geneva WHO Technical Report Series No. 785.
31. World Health Organization, 2004. Expert Consultation on Rabies, First report. Geneva WHO Technical Report Series No. 931.
32. World Health Organization, 2007a. Human and animal rabies; Rabies: A neglected zoonotic disease. Available at: http://www.who.int/rabies/en/.
33. World Health Organization, 2007b. Rabies Surveillance Standards Excerpt from "WHO recommended standards and strategies for surveillance, prevention and control of communicable diseases". Available at: http://www.who.int/rabies/epidemiology/Rabiessurveillance.pdf.
34. World Health Organization, 2002. Weekly Epidemiological Record, No. 14 (77), pp. 109-120, Available at: http://www.who.int/wer.
35. World Health Organization, 1997. WHO guide to good manufacturing practice (GMP) requirements. Part 2: Validation. Chp. 15, Validation of analytical assays. WHO, Geneva, pp. 65-73.
36. Zalan E., Wilson C., and Pukitis D. A microtest for the quantitation of rabies virus neutralizing antibodies. J. Biol. Stand. 7 (1979) 213-220